JNJ-64619178 as an Intervention: 1 Clinical Trial

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

Condition(s):Neoplasms; Solid Tumor, Adult; Non-Hodgkin Lymphoma; Myelodysplastic SyndromesLast Updated:March 15, 2023Active, not recruiting

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.